2008
DOI: 10.1590/s1806-37132008001100014
|View full text |Cite
|
Sign up to set email alerts
|

Ginecomastia: um efeito colateral raro da isoniazida

Abstract: We report the case of a patient who twice developed gynecomastia following tuberculosis treatment. An 18-year-old male developed painful bilateral gynecomastia after three months of treatment with the isoniazid-rifampin-pyrazinamide regimen. Partial resolution of gynecomastia was achieved at the end of treatment. The patient was retreated with the same regimen eight years later, and gynecomastia recurred after six months of treatment. Hormone levels were normal, and a mammogram revealed bilateral gynecomastia.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0
1

Year Published

2011
2011
2020
2020

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(3 citation statements)
references
References 2 publications
(1 reference statement)
0
2
0
1
Order By: Relevance
“…We attribute this to a rare side effect of hydrazide, which has been reported by other authors. ( 9 ) …”
Section: Case Reportmentioning
confidence: 99%
See 1 more Smart Citation
“…We attribute this to a rare side effect of hydrazide, which has been reported by other authors. ( 9 ) …”
Section: Case Reportmentioning
confidence: 99%
“…Atribuímos esse fato a um raro efeito colateral da hidrazida, já observado por outros autores. ( 9 ) …”
Section: Relato De Casounclassified
“…and resolution following its withdrawal strongly supports its causal relationship rather. [12] The exact mechanism of isoniazid causing gynecomastia remains unknown; plausible proposed mechanisms are altered androgen–estrogen due to disturbance in pyridoxine metabolism as well as refeeding syndrome during recovery from chronic illness, which needs further clarification. [11]…”
mentioning
confidence: 99%